Lee TKW - Search Results

1

Identification of KCTD17 as a RAS stabilizer in hepatocellular carcinoma.

Leung RWH, Lee TKW. Leung RWH, et al. Among authors: lee tkw. Clin Mol Hepatol. 2024 Aug 30. doi: 10.3350/cmh.2024.0718. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39218444 Free article. No abstract available.

2

Reply to correspondence regarding "UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma.

Lei MML, Lee TKW. Lei MML, et al. Among authors: lee tkw. Clin Mol Hepatol. 2024 Aug 5. doi: 10.3350/cmh.2024.0621. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39104000 Free article. No abstract available.

3

UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma.

Lei MML, Lee TKW. Lei MML, et al. Among authors: lee tkw. Clin Mol Hepatol. 2024 Jul 23. doi: 10.3350/cmh.2024.0568. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39038959 Free article. No abstract available.

4

The Effectiveness of Auricular Acupressure on Chronic Musculoskeletal Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Lee TKW, Chang JR, Hao D, Fu SN, Wong AYL. Lee TKW, et al. J Integr Complement Med. 2024 Jul 17. doi: 10.1089/jicm.2023.0630. Online ahead of print. J Integr Complement Med. 2024. PMID: 39018502 Review.

5

The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma.

Muliawan GK, Lee TK. Muliawan GK, et al. Front Immunol. 2024 May 29;15:1400112. doi: 10.3389/fimmu.2024.1400112. eCollection 2024. Front Immunol. 2024. PMID: 38868769 Free PMC article. Review.

6

Covalent conjugation of AZD8055 with unsaturated fatty acids for the development of mTOR nanoblockers: increasing the therapeutic efficacy of hepatocellular carcinoma treatment.

Chau WK, Lee TKW. Chau WK, et al. Among authors: lee tkw. EBioMedicine. 2024 May;103:105113. doi: 10.1016/j.ebiom.2024.105113. Epub 2024 Apr 6. EBioMedicine. 2024. PMID: 38583261 Free PMC article. No abstract available.

7

Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer.

Xie Y, Wu H, He Y, Liu L, Huang IB, Zhou L, Lin CY, Leung RW, Loh JJ, Lee TK, Ding J, Man K, Ma S, Tong M. Xie Y, et al. Cell Death Dis. 2024 Feb 3;15(2):110. doi: 10.1038/s41419-024-06493-0. Cell Death Dis. 2024. PMID: 38310091 Free PMC article.

8

CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress.

Lu Y, Chan YT, Wu J, Feng Z, Yuan H, Li Q, Xing T, Xu L, Zhang C, Tan HY, Lee TK, Feng Y, Wang N. Lu Y, et al. Drug Resist Updat. 2023 Nov;71:101015. doi: 10.1016/j.drup.2023.101015. Epub 2023 Oct 29. Drug Resist Updat. 2023. PMID: 37924725 Free article.

9

Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma.

Leung CON, Yang Y, Leung RWH, So KKH, Guo HJ, Lei MML, Muliawan GK, Gao Y, Yu QQ, Yun JP, Ma S, Zhao Q, Lee TKW. Leung CON, et al. Among authors: lee tkw. Nat Commun. 2023 Oct 23;14(1):6699. doi: 10.1038/s41467-023-42360-w. Nat Commun. 2023. PMID: 37872167 Free PMC article.

10

Global trajectory and future prospects of metronomic chemotherapy research: A scientometric analysis (2000-2022).

Khan SA, Chan KYK, Lee TKW. Khan SA, et al. Among authors: lee tkw. Cancer Lett. 2023 Nov 1;576:216401. doi: 10.1016/j.canlet.2023.216401. Epub 2023 Sep 27. Cancer Lett. 2023. PMID: 37774827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters